Skip to main content
Press release November 6, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics, Inc. (ARQT)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site